Turner joined Flagship as an associate after completing the firm’s Fellows Program. As part of a team of entrepreneurial scientists, he develops the science, intellectual property and business strategy that form the foundation of the firm’s breakthrough startups.
Prior to joining Flagship, Turner co-founded a non-profit consultation service for international individuals seeking U.S. cancer treatment. Turner also served as a research assistant at Beth Israel Deaconess Medical Center in Boston, where he developed vaccines for acute myeloid leukemia and multiple myeloma clinical trials, with pre-clinical work focused on vaccine delivery mechanisms. He also worked at the Dana-Farber Cancer Institute, where he researched small molecules focused on inhibiting cancer-causing proteins using micro-RNA technologies.
Turner holds his M.D. from Tufts University School of Medicine and a B.A. with honors in biochemistry from Bowdoin College.